Press Releases, Report

Analysis: Since 2020, Pharmaceutical Industry Spent Over $205M Fighting Against Lower Drug Prices

Economic Security and Corporate Power
August 16, 2022

As the Inflation Reduction Act heads to President Biden’s desk that includes long overdue authority for Medicare to negotiate lower prescription drug prices with big drug companies, an analysis from Accountable.US found the pharmaceutical industry has spent at least $205 million in recent years lobbying and resisting lower drug prices for seniors a

Press Releases, Statement

Statement: Congressional Conservatives Cast Failed Votes to Keep Prices High

Economic Security and Corporate Power
August 12, 2022

Following passage in Congress of President Biden’s widely popular, cost-lowering, deficit-reducing, corporate greed containing Inflation Reduction Act over the objection of all Congressional conservatives, government watchdog Accountable.US released the following statement.

back to top